Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.
Erasca, Inc is a clinical stage precision oncology company singularly focused on discovering, developing and commercializing therapies driven cancers. The headquarters is in USA.
Stevanato Group S.p.A. specializes in world class systems, processes and services for the Pharmaceutical and Healthcare industries company. The headquarters is in Italy.
Stevanato Group S.p.A. annual revenue was 983 million EUR, annual operating income was 192 million EUR and annual net income was 143 million EUR for year ending Dec-2022.
Cochlear Limited is Medical Equipment manufacture and research company based in Australia. Cochlear Limited is the leading global expert in implantable hearing solutions. Cochlear hearing implants are the latest and most innovative hearing implant devices available. Headquarters is in Australia.
As on Jun-2022, Cochlear Limited has Annual Revenue is 1,648 million AUD and net income was 289 million AUD.
As on Jun-2021, Cochlear Limited has Annual Revenue is 1,497 million AUD and net income was 326 million AUD.
As on 2023, Cochlear Limited had 4,800 employees.
Lundbeck is a global pharmaceutical company specialized in brain diseases. Headquarters is in Denmark.
Lundbeck employs approximately 5,800 employees in more than 50 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and California.
Raia Drogasil is the Brazilian Pharmacy Market company.
The Company offers skin care, personal care, and cosmetics products.
The headquarters is in Brazil.
Raia Drogasil has 2300 stores in 24 Brazilian states.
Matsumotokiyoshi Holdings operates and manages chain of drugstore and pharmacy stores in Japan. The company annual revenue is 590.5 billion JPY, annual net income is 26.1 billion JPY, annual operating income is 37.5 billion JPY, total assets is 351.8 billion JPY, total liabilities is 122.4 billion JPY, total equity is 229.3 billion JPY as on 2020. The headquarters is in Japan.
It operates 1,681 drugstores/dispensing pharmacies throughout Japan.